###begin article-title 0
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 244 249 <span type="species:ncbi:10090">Mouse</span>
###xml 262 267 <span type="species:ncbi:10090">mouse</span>
###xml 282 287 <span type="species:ncbi:9606">human</span>
###xml 313 318 <span type="species:ncbi:10090">mouse</span>
###xml 411 416 <span type="species:ncbi:10090">mouse</span>
###xml 450 455 <span type="species:ncbi:10090">mouse</span>
###xml 561 566 <span type="species:ncbi:9606">human</span>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
###xml 772 777 <span type="species:ncbi:10090">mouse</span>
###xml 833 838 <span type="species:ncbi:10090">mouse</span>
###xml 995 1000 <span type="species:ncbi:9606">human</span>
###xml 1101 1106 <span type="species:ncbi:10090">mouse</span>
There is increasing evidence that human arylamine N-acetyltransferase type 1 (NAT1, EC 2.3.1.5), although first identified as a homologue of a drug-metabolising enzyme, appears to be a marker in human oestrogen receptor positive breast cancer. Mouse Nat2 is the mouse equivalent of human NAT1. The development of mouse models of breast cancer is important, and it is essential to explore the biological role of mouse Nat2. We have therefore produced mouse Nat2 as a recombinant protein and have investigated its substrate specificity profile in comparison with human NAT1. In addition, we have tested the effects of inhibitors on mouse Nat2, including compounds which are endogenous and exogenous steroids. We show that tamoxifen, genistein and diethylstilbestrol inhibit mouse Nat2. The steroid analogue, bisphenol A, also inhibits mouse Nat2 enzymic activity and is shown by NMR spectroscopy, through shifts in proton peaks, to bind close to the active site. A three-dimensional structure for human NAT1 has recently been released, and we have used this crystal structure to generate a model of the mouse Nat2 structure. We propose that a conformational change in the structure is required in order for ligands to bind to the active site of the protein.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 10 11 10 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 394 397 394 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">[1]</xref>
###xml 229 232 <span type="species:ncbi:9606">man</span>
Arylamine N-acetyltransferases (NATs, EC 2.3.1.5) have traditionally been identified as drug-metabolising enzymes responsible for the metabolism of arylamines, arylhydroxylamines and arylhydrazines. NATs were first identified in man and a range of eukaryotes and have had an important part to play in the early years of identification of pharmacogenetic variation in response to drug treatment [1].
###end p 6
###begin p 7
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 309 312 309 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">[2]</xref>
###xml 399 402 399 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">[2]</xref>
###xml 447 450 447 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NAT</italic>
###xml 509 515 509 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3 bib4 bib5 bib6 bib7 bib8 bib9 bib10 bib11 bib12" ref-type="bibr">[3&#8211;12]</xref>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">[13]</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 704 708 704 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NAT1</italic>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">[13]</xref>
###xml 64 70 <span type="species:ncbi:9606">humans</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 237 242 <span type="species:ncbi:9606">human</span>
###xml 441 446 <span type="species:ncbi:9606">human</span>
###xml 561 566 <span type="species:ncbi:9606">human</span>
###xml 698 703 <span type="species:ncbi:9606">human</span>
The hydrazine drug isoniazid is polymorphically N-acetylated in humans to its therapeutically inactive form by the human isoenzyme now known as human NAT2. There are two human NAT isoenzymes: human NAT2, which metabolises isoniazid, and human NAT1, which does not metabolise isoniazid or other arylhydrazines [2], but does catalyse the acetylation of a distinct but overlapping series of arylamines [2]. The pattern of expression of the two human NAT genes also differs. As a result of genome-wide microarray [3-12] and proteomic studies [13], it is clear that human NAT1 is highly expressed in oestrogen receptor positive breast cancer [14]. There is also evidence that the level of expression of human NAT1 affects the growth of cultured breast cancer cells [13].
###end p 7
###begin p 8
###xml 204 211 204 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15 bib16 bib17" ref-type="bibr">[15&#8211;17]</xref>
###xml 345 348 345 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">[5]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 705 712 705 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 738 745 738 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18 bib19" ref-type="bibr">[18,19]</xref>
###xml 970 974 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nat2</italic>
###xml 1037 1041 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">[20]</xref>
###xml 1118 1125 1118 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13 bib21" ref-type="bibr">[13,21]</xref>
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 366 371 <span type="species:ncbi:9606">human</span>
###xml 587 592 <span type="species:ncbi:9606">human</span>
###xml 747 751 <span type="species:ncbi:10090">Mice</span>
###xml 834 839 <span type="species:ncbi:10090">mouse</span>
###xml 864 869 <span type="species:ncbi:9606">human</span>
###xml 964 969 <span type="species:ncbi:10090">mouse</span>
###xml 1076 1081 <span type="species:ncbi:9606">human</span>
The role of the human NAT1 enzyme in breast cancer has not been extensively explored, although it has previously been demonstrated that the anti-oestrogen compound tamoxifen is an inhibitor of human NAT1 [15-17]. It has also been demonstrated that both human NAT1 and the oestrogen receptor are down-regulated in tissues in which p53 is mutated [5]. It appears that human NAT1 is a marker for oestrogen receptor positive breast cancer, although information is still accumulating on the relationship of this marker to others, including the oestrogen receptor itself [14]. However, if the human NAT1 enzyme is to be considered as a target for breast cancer therapy, it is essential that there is a suitable in vivo animal model for testing [18,19]. Mice represent the most convenient animal models of disease. At present, the status of mouse Nat2, the equivalent of human NAT1, in a model of breast cancer has not been explored. We have previously demonstrated that mouse Nat2 is expressed in the epithelial cells lining the mammary ducts [20]. This is the same location as the human NAT1 enzyme in normal breast tissue [13,21].
###end p 8
###begin p 9
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
In order to provide a firm foundation for establishing such a model, we have generated pure recombinant mouse Nat2 and investigated its activity with a wide range of substrates and the effects of a range of potential inhibitors, including endogenous and exogenous steroids.
###end p 9
###begin title 10
Materials and methods
###end title 10
###begin title 11
Chemicals
###end title 11
###begin p 12
All chemicals were purchased from Sigma-Aldrich and all molecular biology reagents were purchased from Promega, unless otherwise stated.
###end p 12
###begin title 13
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nat2</italic>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Cloning and expression studies of mouse Nat2
###end title 13
###begin p 14
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nat2</italic>
###xml 34 38 34 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">[22]</xref>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nat2</italic>
###xml 333 349 333 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 1190 1194 1162 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1195 1196 1164 1165 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 1358 1359 1327 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
###xml 301 306 <span type="species:ncbi:10090">mouse</span>
###xml 333 349 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1142 1147 <span type="species:ncbi:10090">mouse</span>
The mouse Nat2 open-reading frame [22] was sub-cloned into pET28b(+) (Novagen) using the compatible restriction enzyme sites, NdeI and EcoRI. This allowed the production of recombinant mouse NAT protein with an N-terminal His-tag, for ease of downstream purification. The pET28b(+) plasmid containing mouse Nat2 was transformed into Escherichia coli strain JM109 and further transformed into Rosetta(DE3)pLysS (Novagen) after confirming the correct insert sequence (DNA Sequencing Facility, Biochemistry, University of Oxford). The positive transformant was grown in LB to mid-log phase at 37 degreesC with shaking (180 rpm) and stored at -80 degreesC with 10% (v/v) glycerol. Thawed glycerol stock (100 muL) was used to inoculate fresh LB media (100 mL) supplemented with kanamycin (30 mug/mL) and chloramphenicol (34 mug/mL) and the culture was incubated at 37 degreesC for 16 h with shaking (180 rpm). The starter culture was then diluted 50-fold into fresh LB media (2 L) supplemented with kanamycin (30 mug/mL), which was then incubated at 27 degreesC with shaking (180 rpm). When the absorbance at 600 nm reached 0.7, the expression of mouse Nat2 was induced by addition of isopropyl-beta-d-thiogalactopyranoside (IPTG) to a final concentration of 0.1 mM. The culture was grown for a further 16 h and the cells were harvested by centrifugation (6000 x g, 4 degreesC, 20 min). The cell pellet was resuspended in 20 mL lysis buffer (300 mM NaCl, 20 mM Tris-HCl (pH 8.0) containing 1x EDTA-free Complete Protease Inhibitor (Roche)) and then stored at -80 degreesC.
###end p 14
###begin p 15
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 86 88 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 108 115 <span type="species:ncbi:562">E. coli</span>
###xml 481 486 <span type="species:ncbi:10090">mouse</span>
For expression of 15N-labelled mouse Nat2, the starter culture was diluted 50-fold in 15N-labelled Standard-E. coli-OD2 N medium (Silantes) supplemented with kanamycin (30 mug/mL) and grown at 37 degreesC until the absorbance at 600 nm reached approximately 0.6. The cells were further grown at 27 degreesC until the absorbance reached 0.7, when the expression was induced with 0.1 mM IPTG. After induction for 17 h, the cells were harvested and stored as described for unlabelled mouse Nat2.
###end p 15
###begin p 16
###xml 202 203 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
The resuspended frozen cells were thawed at 37 degreesC and sonicated on ice (25 cycles of 30 s on, 45 s off at 10 mum). The soluble lysate was isolated from the cell debris by centrifugation (12,000 x g, 4 degreesC, 20 min) and incubated (4 degreesC, 5 min) with 5 mL of Ni-NTA resin (Qiagen). The resin was sequentially washed with lysis buffer containing increasing imidazole concentrations in a step gradient at 4 degreesC (2 washes each of 10 mL of 0 mM, 10 mM, 20 mM, 50 mM and 100 mM imidazole). Fractions containing hexa-histidine tagged Nat2 (His-Nat2), were pooled and thrombin (5 U/mg NAT) was added to remove the His-tag. After 16 h incubation at 4 degreesC, the protein sample was dialysed against 20 mM Tris-HCl (pH 8.0), 1 mM dithiothreitol (DTT), 1 mM EDTA buffer, and concentrated to 1 mg/mL by centrifugation in a 15 mL concentrator (Amicon) after addition of 5% (v/v) glycerol. Protein samples in 100 muL aliquots were frozen in liquid nitrogen and stored at -80 degreesC.
###end p 16
###begin p 17
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">[23]</xref>
###xml 82 84 82 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 149 151 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
Recombinant hamster Nat2 was expressed and purified as previously described [23]. 15N-labelled hamster Nat2 was grown and expressed as described for 15N-labelled mouse Nat2 and purified by the same method as for the unlabelled hamster Nat2.
###end p 17
###begin p 18
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr">[24]</xref>
The expression levels and activities of soluble Nat2 were monitored by visualizing the levels of recombinant protein expression on 12% acrylamide Tris-Glycine SDS-PAGE as well as by measuring the rate of acetylation of 4-aminobenzoic acid (PABA) as a substrate (see method below) [24].
###end p 18
###begin title 19
Enzymic assays
###end title 19
###begin title 20
Acetylation of arylamines
###end title 20
###begin p 21
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr">[25]</xref>
###xml 613 614 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 740 743 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N,N</italic>
The rates of arylamine acetylation by NATs were determined colorimetrically as previously described [25], but with minor modifications. Each assay contained the enzyme, arylamine substrate (see each figure legends for concentrations) and AcCoA (400 muM) in a total volume of 100 muL in assay buffer (20 mM Tris-HCl (pH 8.0), 1 mM DTT). Initially, the enzyme and substrate mixtures were pre-incubated at 25 degreesC for 5 min and AcCoA was added to start the reaction. The reaction was quenched using 20% (w/v) trichloroacetic acid (TCA) at different time intervals. The stopped reaction was centrifuged (16,000 x g rpm, 10 min) to pellet the precipitated proteins. The stopped reaction mixture (200 muL) was added to 800 muL of 5% (w/v) 4-(N,N-dimethylamino)benzaldehyde (DMAB) in 9:1 acetonitrile:water to develop the colour. The absorption at 450 nm was measured with a Hitachi U-2001 UV-vis spectrophotometer, with the amount of residual substrate in the reaction was determined by comparison with a standard curve.
###end p 21
###begin title 22
Hydrolysis of AcCoA (free CoA production)
###end title 22
###begin p 23
###xml 238 244 238 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib26" ref-type="bibr">[2,26]</xref>
###xml 390 393 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
The rate of production of the free thiol Coenzyme A by NAT, in the presence of a range of known NAT acetyl-acceptor substrates, was determined by using Ellman's reagent, 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB) as previously described [2,26]. The substrate (500 muM) and purified recombinant NAT were pre-incubated (25 degreesC, 5 min) in 96-well flat-bottomed polystyrene plates (Costar(R), Corning Inc.) in 20 mM Tris-HCl (pH 8.0). AcCoA (400 muM) was added to start the reaction in a final volume of 100 muL. The reaction was quenched with the addition of 25 muL of guanidine-HCl solution (6.4 M guanidine-HCl, 0.1 M Tris-HCl (pH 7.3)) containing 5 mM DTNB. The absorbance at 405 nm was measured on a plate-reader (Sunrise, Tecan). Assay buffer was used to replace substrate, AcCoA or NAT for control reactions. The amount of CoA produced in the assay was determined in comparison with a CoA standard curve.
###end p 23
###begin p 24
###xml 428 429 428 429 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
Substrate abbreviations used for the substrate selectivity assays are as follows: aniline (ANL), 4-aminobenzoic acid (PABA), 4-aminosalicylic acid (4AS), 5-aminosalicylic acid (5AS), 4-chloroaniline (CLA), 4-bromoaniline (BRA), 4-iodoaniline (IOA), 4-methoxyanline (ANS), 4-ethoxyaniline (EOA), 4-butoxyanline (BOA), 4-hexyloxyaniline (HOA), 4-phenoxyaniline (POA), 4-aminoveratrole (4AV), 2-aminofluorene (2AF), 4-aminobenzoyl-l-glutamate (pABGlu), sulfamethazine (SMZ), procainamide (PRO), 4-aminopyridine (APY), isoniazid (INH), hydralazine (HDZ) and phenylhydrazine (PHZ). The stock concentration of substrate was 100 mM dissolved in DMSO, such that the final concentration of DMSO was less than 5% in the assays. DMSO only controls were carried out.
###end p 24
###begin title 25
NMR spectroscopy
###end title 25
###begin p 26
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 10 12 10 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 229 231 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 261 262 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 268 269 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 352 353 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 360 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 429 430 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 430 431 424 425 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 436 437 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 437 438 431 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 242 247 <span type="species:ncbi:10090">mouse</span>
The 2D 1H-15N HSQC spectrum of mouse Nat2 was collected using a 750 MHz NMR spectrometer (Department of Biochemistry, University of Oxford). The spectrum was collected at 20 degreesC for a sample containing 30 mg/mL of uniformly 15N-labelled mouse Nat2 in 95% H2O/5% D2O 10 mM Tris buffer at pH 7.0. Spectral widths of 12,500 and 2500 Hz were used in F2 and F1, respectively. The dataset contained 1024 and 128 complex points in t2 and t1, respectively.
###end p 26
###begin p 27
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 147 148 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 200 201 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 313 318 <span type="species:ncbi:10090">mouse</span>
###xml 413 418 <span type="species:ncbi:10090">mouse</span>
###xml 583 588 <span type="species:ncbi:10090">mouse</span>
###xml 731 736 <span type="species:ncbi:10090">mouse</span>
1D 1H NMR spectra for hamster and mouse Nat2 were collected at 20 degreesC using a jump-return sequence. This sequence enabled the observation of HN peaks which exchange to a significant extent with H2O. Spectra were collected using a 600 MHz spectrometer using a sweep width of 12,500 Hz. Unlabelled hamster and mouse Nat2 were used at a concentration of 10 mg/mL in the buffer described above. The titration of mouse Nat2 with bisphenol A was carried out by stepwise addition of small volumes (5-20 muL) of a concentrated solution of bisphenol A (100 mM in deuterated DMSO) to the mouse Nat2 solution in the NMR tube. The highest concentration of DMSO in the sample used was 2.8%. DMSO alone had no effect on the NMR spectrum of mouse Nat2 using concentrations up to 5%.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nat2</italic>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Cloning and expression of mouse Nat2
###end title 29
###begin p 30
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nat2</italic>
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 84 91 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 288 294 288 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 437 443 437 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27" ref-type="bibr">[27]</xref>
###xml 588 595 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 31 38 <span type="species:ncbi:562">E. coli</span>
###xml 84 91 <span type="species:ncbi:562">E. coli</span>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
###xml 571 576 <span type="species:ncbi:10090">mouse</span>
The mouse Nat2 was cloned into E. coli expression vector pET28b(+) and expressed in E. coli Rosetta (DE3)pLysS with an N-terminal hexa-histidine tag. The recombinant mouse His-Nat2 was purified using immobilised metal affinity chromatography, using a Ni-NTA column (Novagen), and eluted (Fig. 1a). Pure Nat2 predominantly eluted in the 50 mM and 100 mM imidazole washes. The hexa-histidine tag was readily removed by thrombin digestion (Fig. 1b). The purified recombinant Nat2 was active, readily catalysing the acetylation of PABA, a well-studied arylamine substrate of mouse Nat2 [27] (Table 1). The enzyme was relatively stable, and the enzymic activity was maintained (>85%) after incubation at temperatures ranging between 4 degreesC and 25 degreesC over a 72 h period.
###end p 30
###begin title 31
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Substrate specificity of mouse Nat2
###end title 31
###begin p 32
###xml 370 373 370 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">[2]</xref>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
###xml 295 300 <span type="species:ncbi:10090">mouse</span>
To further characterise the purified recombinant mouse Nat2, a panel of known NAT substrates (20 compounds) was tested to determine the substrate selectivity of recombinant mouse Nat2. In order to allow direct comparison with substrate selectivity profile for human NAT1 and NAT2, the assay for mouse Nat2 was performed under the same conditions as previously described [2].
###end p 32
###begin p 33
###xml 110 116 110 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 121 142 121 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Table 1</xref>
###xml 320 326 320 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 493 503 493 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22 bib27 bib28" ref-type="bibr">[22,27,28]</xref>
###xml 599 605 599 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr">[28]</xref>
###xml 1175 1179 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr">[29]</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 448 453 <span type="species:ncbi:10090">mouse</span>
###xml 587 592 <span type="species:ncbi:9606">human</span>
###xml 692 697 <span type="species:ncbi:10090">mouse</span>
###xml 770 775 <span type="species:ncbi:10090">mouse</span>
###xml 847 852 <span type="species:ncbi:10090">mouse</span>
###xml 945 950 <span type="species:ncbi:10090">mouse</span>
###xml 986 991 <span type="species:ncbi:10090">mouse</span>
Mouse Nat2 shows high specific activities with a broad range of arylamines, including PABA, 5AS, 4AS and 2AF (Fig. 2 and Supplementary Table 1). In contrast, mouse Nat2 shows low specific activities against arylhydrazine substrates such as HDZ, INH, and PHZ, and against arylamine drugs procainamide and sulfamethazine (Fig. 2). This overall trend is in agreement with the substrate selectivity observed in previous studies with impure recombinant mouse Nat2 using a subset of these compounds [22,27,28], although it is much less than the activity observed towards these substrates with human NAT2 (Fig. 2). There was low, yet measurable activity using arylhydrazine substrates with purified mouse Nat2, which has not been observed in previous studies using recombinant mouse Nat2 expressed in a transient expression system [28]. Pure recombinant mouse Nat2 also readily acetylates 2-aminofluorene, the substrate which has been used to identify mouse strains carrying an active form of mouse Nat2-the fast acetylating C57Bl/6 strain, rather than the inactive form as is found in the slow acetylating A/J strain which is unstable and likely to be subject to rapid degradation [29].
###end p 33
###begin p 34
###xml 44 47 44 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">[2]</xref>
###xml 86 92 86 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 482 485 482 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">[2]</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 180 185 <span type="species:ncbi:10090">Mouse</span>
###xml 238 243 <span type="species:ncbi:9606">human</span>
###xml 275 280 <span type="species:ncbi:10090">mouse</span>
###xml 339 344 <span type="species:ncbi:9606">human</span>
###xml 429 434 <span type="species:ncbi:9606">human</span>
The specific activity pattern of human NAT1 [2] overlaps with the mouse Nat2 profile (Fig. 2), reconfirming that mouse Nat2 is very similar to human NAT1 in substrate specificity. Mouse Nat2 shows differences from the activity profile of human NAT1, however. It appears that mouse Nat2 generally has higher inherent specific activity than human NAT1 and also acetylates arylhydrazines, when the acetylation of these compounds by human NAT1 is not detected under the same conditions [2].
###end p 34
###begin title 35
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Nat2 inhibition by steroidogenic compounds
###end title 35
###begin p 36
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NAT1</italic>
###xml 148 155 148 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15 bib16 bib17" ref-type="bibr">[15&#8211;17]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 211 216 <span type="species:ncbi:9606">human</span>
###xml 421 426 <span type="species:ncbi:10090">mouse</span>
It had been demonstrated, with extracts of tissues and cells now known to express the human NAT1 gene, that tamoxifen is an inhibitor of human NAT1 [15-17]. In view of the relationship between the expression of human NAT1 and oestrogen receptor positivity in breast cancer [14], we wished to investigate the effects of steroidogenic compounds and xenobiotic oestrogenic compounds, including tamoxifen, on the activity of mouse Nat2.
###end p 36
###begin p 37
###xml 238 245 235 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 250 270 247 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 1</xref>
###xml 392 394 389 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 436 443 433 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">Table 3</xref>
###xml 599 603 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 699 704 <span type="species:ncbi:10090">mouse</span>
From the inhibition study using a broad range of steroidogenic compounds, it has been demonstrated that mouse Nat2 is inhibited selectively by oestrogenic compounds, with 17-hydroxy-beta-estradiol identified as the most potent inhibitor (Table 2 and Supplementary Fig. 1). This was substantiated by the inhibition of mouse Nat2 activity by xenobiotic oestrogens, such as tamoxifen, and the IC50 values for these inhibitors are shown in Table 3. The phytoestrogens genistein, alpha-zearalenol and the synthetic oestrogen diethylstilbestrol show similar potency of mouse Nat2 inhibition to 17-hydroxy-beta-estradiol, tamoxifen and 4-hydroxy tamoxifen. Bisphenol A was also shown to be an inhibitor of mouse Nat2, albeit with lower potency than some of the other compounds tested. One key practical advantage of using bisphenol A as an inhibitor is the improved solubility of this compound relative to the other phytoestrogens and steroids.
###end p 37
###begin title 38
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Structure of mouse Nat2
###end title 38
###begin p 39
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">[30]</xref>
###xml 394 395 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 841 853 841 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. smegmatis</italic>
###xml 855 861 855 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1013 1017 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31" ref-type="bibr">[31]</xref>
###xml 1037 1043 1037 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1702 1723 1702 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium marinum</italic>
###xml 1755 1759 1755 1759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib32" ref-type="bibr">[32]</xref>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 283 288 <span type="species:ncbi:9606">human</span>
###xml 606 611 <span type="species:ncbi:9606">human</span>
###xml 688 693 <span type="species:ncbi:9606">human</span>
###xml 783 788 <span type="species:ncbi:9606">human</span>
###xml 841 853 <span type="species:ncbi:1772">M. smegmatis</span>
###xml 1100 1105 <span type="species:ncbi:9606">human</span>
###xml 1434 1439 <span type="species:ncbi:9606">human</span>
###xml 1702 1723 <span type="species:ncbi:1781">Mycobacterium marinum</span>
Until recently, there has been no structural information on eukaryotic NAT enzymes. However, recently the three-dimensional structure of a human NAT1 mutant (Phe/Ser substitution at position 125) was determined by X-ray crystallography (PDB accession code: 2IJA [30]). A non-mutated human NAT1 crystal structure has also been deposited in which the active-site cysteine residue was modified to S-(2-anilino-2-oxoethyl)-cysteine (PDB accession code: 2PQT). It is considered likely that both the mutation of residue 125 and the modification of the active-site cysteine residue stabilise the structure of the human enzyme, because thousands of attempts to generate a crystal from the native human NAT1 protein have been unsuccessful (A. Kawamura, unpublished results). The structure of human NAT1 is illustrated in comparison with the NAT from M. smegmatis (Fig. 3). The eukaryotic proteins contain a loop between the second and third domains. This inter-domain loop is not present in their prokaryotic counterparts [31], as highlighted in Fig. 3. It is interesting to note that in the structure of the human NAT1 enzyme, this inter-domain loop is folded back over the active site. Likewise, the C-terminus is shown to be folded over the active-site cleft. These observations indicate that a conformational change in the protein may be required to allow the substrates to access the active-site cysteine residue. However, a structure of human NAT2 with coenzyme A bound has also been deposited (PDB accession code: 2PFR), and the position of the coenzyme A is such that the C-terminus and inter-domain loops regions are not significantly changed. This is in contrast to the recently reported structure of Mycobacterium marinum NAT in complex with coenzyme A [32]. In this bacterial NAT, the C-terminus is shorter than in the eukaryotic structures, and there is no inter-domain loop, and the ligand is found in the space where these regions are located in the eukaryotic structure.
###end p 39
###begin p 40
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">[33]</xref>
###xml 167 173 167 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 254 259 <span type="species:ncbi:9606">human</span>
###xml 390 395 <span type="species:ncbi:10090">mouse</span>
###xml 408 413 <span type="species:ncbi:9606">human</span>
###xml 533 538 <span type="species:ncbi:9606">human</span>
###xml 696 701 <span type="species:ncbi:10090">mouse</span>
###xml 710 715 <span type="species:ncbi:9606">human</span>
We have generated a structural model of the mouse Nat2 protein, whose amino acid sequence is over 80% identical to human NAT1, by using the program Modeller 8v2 [33]. Fig. 4 shows the structural model of mouse Nat2 and a comparison of the mouse Nat2 and human NAT1 protein structures. The two structures share 1191 equivalent atoms, over which the root mean squared deviation is 0.75 A. In mouse Nat2, as in human NAT1, the inter-domain loop and the C-terminus occlude the active site. Despite the evidence for coenzyme A binding to human NAT2 without major conformational rearrangement of the C-terminus and inter-domain loop regions, it has not been possible to perform ligand docking into the mouse Nat2 or human NAT1 structures without disturbing these regions of the protein structure. Therefore, it remains possible that the inter-domain loop regions and C-termini of the eukaryotic NAT proteins are conformationally flexible, in order to accommodate substrate or inhibitor binding.
###end p 40
###begin title 41
NMR studies
###end title 41
###begin p 42
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 227 228 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 230 232 230 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 274 280 274 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 337 338 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 339 340 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 341 343 341 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr">[34]</xref>
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
###xml 251 256 <span type="species:ncbi:10090">mouse</span>
###xml 613 618 <span type="species:ncbi:10090">mouse</span>
###xml 678 683 <span type="species:ncbi:10090">mouse</span>
###xml 938 943 <span type="species:ncbi:10090">mouse</span>
NMR studies are ideal for investigating protein interactions with substrates and inhibitors in solution. Therefore, we have generated mouse Nat2 uniformly labelled with 15N to allow 2D NMR investigations of the protein. The 2D 1H-15N HSQC spectrum of mouse Nat2 is shown in Fig. 5; this spectrum contains a peak for each backbone amide (1HN-15N) and additional peaks from the side chains of Asn, Gln and Trp. The HSQC spectrum is well resolved, as expected for a compact globular structure, and some cross peaks are relatively sharp for a 30 kDa protein, this may indicate some flexibility between the domains of mouse Nat2 or the presence of mobile loops. The HSQC spectrum of mouse Nat2 has been compared with the corresponding spectrum from hamster Nat2 for which a full assignment is available [34]. The pattern of peaks in the HSQC spectra is extremely similar for the two homologous proteins; this allows some peaks observed in the mouse Nat2 spectrum to be assigned on the basis of the hamster Nat2 spectrum.
###end p 42
###begin p 43
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 146 152 146 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 193 200 193 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl4" ref-type="table">Table 4</xref>
###xml 481 484 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">132</sup>
###xml 490 496 490 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 505 507 505 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">67</sup>
###xml 557 559 557 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">68</sup>
###xml 831 832 819 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 833 834 821 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 864 866 852 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 971 972 959 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 973 974 961 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 1232 1233 1220 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 1234 1235 1222 1223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 1402 1405 1390 1393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">107</sup>
###xml 1477 1480 1465 1468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">107</sup>
###xml 1743 1747 1731 1735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35" ref-type="bibr">[35]</xref>
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
###xml 336 341 <span type="species:ncbi:10090">mouse</span>
###xml 1302 1307 <span type="species:ncbi:10090">mouse</span>
###xml 1429 1434 <span type="species:ncbi:10090">mouse</span>
The downfield region of the 1H 1D spectra, collected with a jump-return sequence, of mouse and hamster Nat2 also show a similar pattern of peaks (Fig. 6A and B). The four peaks are compared in Table 4, together with their assignments. Two of the peaks (2 and 3) have been assigned previously for hamster Nat2 and can be assigned in the mouse spectrum by homology; these correspond to strongly hydrogen bonded tryptophan indole groups: the tryptophan associated with the P-loop (Trp132, see Fig. 7) and Trp67, which is located adjacent to the active-site Cys68, and appears to have a structural role. The strong hydrogen bonds are likely to be responsible for the large downfield shifts of these tryptophan peaks compared to random coil values (approximately9.5 ppm). The two remaining peaks (1 and 4) are assigned to the imidazole 1HN of histidine on the basis of 15N decoupling experiments; these peaks have not been assigned previously for hamster Nat2. The side chain 1HN groups of histidine are usually not observed by NMR, particularly at pH 7, due to their rapid exchange with solvent protons. The observation of these peaks indicates that the histidine residues are probably buried within the protein and that the side chain 1HN are involved in hydrogen bonds. Analysis of the homology model of mouse Nat2 suggests that at least one of these peaks might arise from the active site histidine, His107. The homology model of mouse Nat 2 indicates that the side chain of His107 is involved in two hydrogen bonds in the active site and is the least accessible to solvent. In addition, recent enzymological studies with hamster Nat2 have confirmed that the active-site cysteine and histidine residues exist as a thiolate-imidazolium ion pair [35], in which the histidine has two tightly bound and H-bonded protons.
###end p 43
###begin title 44
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
Interaction of mouse Nat2 with exogenous steroid inhibitors
###end title 44
###begin p 45
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 185 198 185 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig8 fig9" ref-type="fig">Figs. 8 and 9</xref>
###xml 549 556 549 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl4" ref-type="table">Table 4</xref>
###xml 604 610 604 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 825 826 801 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 833 835 809 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">67</sup>
###xml 843 846 819 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">132</sup>
###xml 848 854 824 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig9" ref-type="fig">Fig. 9</xref>
###xml 1080 1082 1056 1058 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1210 1213 1183 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">107</sup>
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 493 498 <span type="species:ncbi:10090">mouse</span>
###xml 1050 1055 <span type="species:ncbi:10090">mouse</span>
###xml 1338 1343 <span type="species:ncbi:10090">mouse</span>
In order to probe the molecular interactions of mouse Nat2 and the exogenous steroid inhibitors, we have investigated the effect of bisphenol A on the 1D 1H NMR spectrum of mouse Nat2 (Figs. 8 and 9). The observation of changes in chemical shift for particular amino acid residues which result from the addition of a ligand are usually interpreted as an indication that these residues are located in close proximity to the ligand-binding site. When bisphenol A was titrated into a solution of mouse Nat2, the two downfield histidine peaks (1 and 4, Table 4) were observed to shift by more than 0.05 ppm (Fig. 9); peak 1 shifts downfield by approximately0.12 ppm and peak 4 shifts upfield by approximately0.08 ppm in the presence of 8 equivalents of bisphenol A. Additional small shifts were also observed for the side chain HN of Trp67 and Trp132 (Fig. 9). The observation of progressive changes in chemical shift upon addition of bisphenol A indicates fast exchange on the NMR timescale; this would be expected given the relatively weak affinity of mouse Nat2 for this ligand (IC50 = 290 +/- 10 muM). We have postulated above that at least one of the histidine peaks arises from the active-site histidine, His107; therefore, these results show that binding of bisphenol A is likely to take place in close proximity to the active site of mouse Nat2.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nat2</italic>
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nat2</italic>
###xml 619 623 619 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36" ref-type="bibr">[36]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr">[37]</xref>
###xml 851 858 851 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib38" ref-type="bibr">[38]</xref>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 354 359 <span type="species:ncbi:9606">human</span>
###xml 393 398 <span type="species:ncbi:10090">mouse</span>
###xml 413 418 <span type="species:ncbi:9606">human</span>
###xml 427 432 <span type="species:ncbi:10090">mouse</span>
###xml 459 464 <span type="species:ncbi:10090">mouse</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 829 834 <span type="species:ncbi:10090">mouse</span>
###xml 927 932 <span type="species:ncbi:9606">human</span>
###xml 1085 1090 <span type="species:ncbi:10090">mouse</span>
###xml 1115 1120 <span type="species:ncbi:9606">human</span>
###xml 1156 1161 <span type="species:ncbi:10090">mouse</span>
###xml 1190 1195 <span type="species:ncbi:9606">human</span>
###xml 1202 1207 <span type="species:ncbi:10090">Mouse</span>
###xml 1266 1271 <span type="species:ncbi:9606">human</span>
The possibility that human NAT1 may serve as a marker for sub-dividing populations of different breast cancers is intriguing. It may also be that human NAT1 will find a role as a target for breast cancer therapies. In order to exploit these findings fully, it will be essential to have an animal model. There have been, for a long time, suggestions that human NAT1 has an endogenous role. The mouse equivalent of human NAT1 is mouse Nat2. Genetic deletion of mouse Nat2 has not created an overt phenotype; however, some of these studies in mice indicate that Nat2 deletion gives rise to skewed sex ratios both on mixed [36] and pure [37] genetic backgrounds, indicating a gender-dependent phenotype, discernable at the population level, that is consistent with a role in endocrine function. There is now also clear evidence that mouse Nat2 has a role in vivo in folate catabolism [38]. These studies, together with the data on human NAT1 and breast cancer, are intriguing and are likely to provide clues as to the endogenous role of NAT1. The data presented increases the knowledge of mouse Nat2 in comparison with human NAT1 and reinforce the notion that mouse Nat2 is a good homologue of human NAT1. Mouse Nat2 has a similar substrate specific activity profile to human NAT1.
###end p 47
###begin p 48
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39" ref-type="bibr">[39]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib40" ref-type="bibr">[40]</xref>
###xml 848 852 848 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib41" ref-type="bibr">[41]</xref>
###xml 1021 1028 1021 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib41 bib42 bib43 bib44" ref-type="bibr">[41&#8211;44]</xref>
###xml 1403 1407 1402 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib45" ref-type="bibr">[45]</xref>
###xml 1482 1486 1481 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46" ref-type="bibr">[46]</xref>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
###xml 1253 1258 <span type="species:ncbi:10090">mouse</span>
The inhibition studies show that mouse Nat2 is inhibited by endogenous steroids and, like human NAT1, is inhibited by tamoxifen. Bisphenol A, which is used for making polycarbonates [39], has been reported to activate the oestrogen receptor [40]. Like tamoxifen, it is also an inhibitor of mouse Nat2. We have used bisphenol A to look at the binding of an oestrogenic stimulatory compound to mouse Nat2 and show by NMR that bisphenol A interacts with mouse Nat2 close to the active site region. These studies could not be done directly with tamoxifen because of the high concentrations of protein (and hence ligand) required for NMR experiments under which conditions tamoxifen is insoluble. Both endogenous and xenobiotic oestrogens have been shown to modify breast cancer risk, and tamoxifen is widely used for breast cancer therapy (reviewed in [41]). The effect of different synthetic or natural oestrogens on cell proliferation has been analysed directly, in breast cancer cell lines, and in gene expression studies [41-44]. Although the dose-response curves for different oestrogenic compounds vary with the assay system, bisphenol A is generally less active than tamoxifen, genistein or diethylstilbestrol, which reflects the order of potency of mouse Nat2 inhibition. Circulating plasma concentrations of the phytoestogen genistein have been found to be as high as 18 muM after a soy-based meal [45], and intratumoral levels of tamoxifen can reach micromolar concentrations [46]. Whether the effects on inhibition of Nat2 activity in vitro may be physiologically relevant for breast cancer prevention or therapy will require further analysis.
###end p 48
###begin p 49
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">[20]</xref>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
###xml 373 378 <span type="species:ncbi:10090">mouse</span>
###xml 459 464 <span type="species:ncbi:9606">human</span>
###xml 471 476 <span type="species:ncbi:9606">human</span>
###xml 483 488 <span type="species:ncbi:10090">mouse</span>
###xml 498 503 <span type="species:ncbi:10090">mouse</span>
###xml 613 618 <span type="species:ncbi:9606">human</span>
###xml 632 637 <span type="species:ncbi:10090">mouse</span>
###xml 853 859 <span type="species:ncbi:9606">humans</span>
These studies pave the way for investigation of the role of mouse Nat2, the human NAT1 homologue, in studies of oestrogen receptor positive breast cancer. This is particularly relevant in view of the observation that mouse Nat2 is located histologically in the mammary gland epithelial cells [20]. The structural studies also provide a rational basis for identification of mouse Nat2 inhibitors. We have recently screened a 5000-strong compound library using human NAT1, human NAT2, mouse Nat1 and mouse Nat2; from these studies, several compounds been have identified which are potent and specific inhibitors of human NAT1 and its mouse homologue, Nat2. An accumulation of information on the eukaryotic NAT proteins at a structural level will allow further development of chemical tools for investigation of the role of this marker in breast cancer in humans, and its potential in animal models.
###end p 49
###begin title 50
Supplementary data
###end title 50
###begin p 51
Supplementary data associated with this article can be found, in the online version, at .
###end p 51
###begin title 52
Supplementary data
###end title 52
###begin p 53
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">2</xref>
###xml 692 693 681 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">2</xref>
###xml 1030 1030 1017 1017 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc1.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint"/>
###xml 1030 1030 1017 1017 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1c7ece0N0x2d8dfa0"><media xlink:href="mmc1.ppt" mimetype="application" mime-subtype="vnd.ms-powerpoint"/></supplementary-material>
###xml 1030 1030 1017 1017 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc2.doc" mimetype="application" mime-subtype="msword"/>
###xml 1030 1030 1017 1017 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1c7ece0N0x2d8e060"><media xlink:href="mmc2.doc" mimetype="application" mime-subtype="msword"/></supplementary-material>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
###xml 326 331 <span type="species:ncbi:10090">mouse</span>
Supplementary Fig. 1 Inhibition of purified recombinant Nat2 by steroids. The inhibitory effect of steroids on the rate of acetylation of arylamines by mouse Nat2 was measured by using the colorimetric DMAB assay as described in Section 2. Test compounds (50 muM, 2% DMSO unless specified) were pre-incubated with recombinant mouse Nat2 (3 ng) and PABA (75 muM) for 10 min at room temperature. AcCoA (400 muM) was added to start the reaction and the reaction mixture was incubated at 37 degreesC. The total reaction volume was 100 muL. Reactions were stopped at various time intervals by the addition of 100 muL of 20% (w/v) TCA. The colour was developed and measured as described in Section 2. The linear initial rate of reaction was determined and the percentage inhibition was calculated relative to the control activity measured without the inhibitor. All measurements were performed in triplicate and are expressed as mean +/- standard deviation. *2% (v/v) ethanol **5% (v/v) DMSO used to dissolve the compounds in the assay.
###end p 53
###begin title 54
Acknowledgements
###end title 54
###begin p 55
The authors thank Lindsay Johnson and Dee Perera for help with preparation of the manuscript and James Sandy, Angela Russell and Steve Davies for helpful discussions. We are grateful to the Wellcome Trust for financial support. Kylie Walters is in receipt of a grant from the American Cancer Society.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
Arylamine N-acetyltransferases
###end article-title 57
###begin article-title 58
Eukaryotic arylamine N-acetyltransferase Investigation of substrate specificity by high-throughput screening
###end article-title 58
###begin article-title 59
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
###end article-title 59
###begin article-title 60
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
###end article-title 60
###begin article-title 61
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 117 124 <span type="species:ncbi:9606">patient</span>
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
###end article-title 61
###begin article-title 62
###xml 40 45 <span type="species:ncbi:9606">human</span>
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
###end article-title 62
###begin article-title 63
###xml 112 117 <span type="species:ncbi:9606">human</span>
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
###end article-title 63
###begin article-title 64
###xml 42 47 <span type="species:ncbi:9606">human</span>
X chromosomal abnormalities in basal-like human breast cancer
###end article-title 64
###begin article-title 65
A gene-expression signature as a predictor of survival in breast cancer
###end article-title 65
###begin article-title 66
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
###end article-title 66
###begin article-title 67
A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors
###end article-title 67
###begin article-title 68
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
###end article-title 68
###begin article-title 69
Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro
###end article-title 69
###begin article-title 70
Arylamine N-acetyltransferase I expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors
###end article-title 70
###begin article-title 71
###xml 58 63 <span type="species:ncbi:9606">human</span>
Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer
###end article-title 71
###begin article-title 72
###xml 92 97 <span type="species:ncbi:9606">human</span>
Effects of tamoxifen on DNA adduct formation and arylamines N-acetyltransferase activity in human breast cancer cells
###end article-title 72
###begin article-title 73
###xml 92 97 <span type="species:ncbi:9606">human</span>
Tamoxifen inhibits arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human leukemia HL-60 cells
###end article-title 73
###begin article-title 74
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
mILC-ing the mouse mammary gland: a model for invasive lobular carcinoma
###end article-title 74
###begin article-title 75
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
The mighty mouse: genetically engineered mouse models in cancer drug development
###end article-title 75
###begin article-title 76
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system
###end article-title 76
###begin article-title 77
N-Acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast
###end article-title 77
###begin article-title 78
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro
###end article-title 78
###begin article-title 79
Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies
###end article-title 79
###begin article-title 80
###xml 101 123 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Purification, characterisation and crystallisation of an N-hydroxyarylamine O-acetyltransferase from Salmonella typhimurium
###end article-title 80
###begin article-title 81
###xml 69 74 <span type="species:ncbi:9606">human</span>
A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis
###end article-title 81
###begin article-title 82
An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases
###end article-title 82
###begin article-title 83
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products
###end article-title 83
###begin article-title 84
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Substrate selectivity of mouse N-acetyltransferases 1, 2 and 3 expressed in Cos-1 cells
###end article-title 84
###begin article-title 85
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Metabolic, molecular genetic and toxicological aspects of the acetylation polymorphism in inbred mice
###end article-title 85
###begin article-title 86
###xml 53 58 <span type="species:ncbi:9606">human</span>
Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases
###end article-title 86
###begin article-title 87
Eubacterial arylamine N-acetyltransferases-identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues
###end article-title 87
###begin article-title 88
Divergence of co-factor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase
###end article-title 88
###begin article-title 89
Comparative protein modelling by satisfaction of spatial restraints
###end article-title 89
###begin article-title 90
NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity
###end article-title 90
###begin article-title 91
Catalytic mechanism of hamster arylamine N-acetyltransferase 2
###end article-title 91
###begin article-title 92
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene
###end article-title 92
###begin article-title 93
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Neuroendocrine expression of mouse arylamine N-acetyltransferase 2
###end article-title 93
###begin article-title 94
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism
###end article-title 94
###begin article-title 95
Weight of the evidence evaluation of low-dose reproductive and developmental effects of bisphenol A
###end article-title 95
###begin article-title 96
###xml 54 59 <span type="species:ncbi:9606">human</span>
Bisphenol-A, an environmental estrogen, activates the human orphan nuclear receptor, steroid and xenobiotic receptor-mediated transcription
###end article-title 96
###begin article-title 97
The role of xenoestrogenic compounds in the development of breast cancer
###end article-title 97
###begin article-title 98
Estrogen-related receptors as emerging targets in cancer and metabolic disorders
###end article-title 98
###begin article-title 99
Activation of kinase pathways in MCF-7 cells by 17beta-estradiol and structurally diverse estrogenic compounds
###end article-title 99
###begin article-title 100
Kinetic analysis of estrogen receptor/ligand interactions
###end article-title 100
###begin article-title 101
###xml 127 132 <span type="species:ncbi:9606">human</span>
Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells
###end article-title 101
###begin article-title 102
Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial
###end article-title 102
###begin article-title 103
###xml 56 78 <span type="species:ncbi:90371">Salmonella typhimurium</span>
The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity
###end article-title 103
###begin article-title 104
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
###end article-title 104
###begin article-title 105
Structure of arylamine N-acetyltransferase reveals a catalytic triad
###end article-title 105
###begin p 106
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 179 186 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 70 77 <span type="species:ncbi:562">E. coli</span>
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
###xml 152 157 <span type="species:ncbi:10090">Mouse</span>
###xml 179 186 <span type="species:ncbi:562">E. coli</span>
Heterologous expression and purification of recombinant mouse Nat2 in E. coli. SDS-PAGE analysis of expression and affinity purification of mouse Nat2. Mouse Nat2 was produced in E. coli Rosetta(DE3)pLysS strain and purified by Ni-NTA affinity chromatography. The purification gel shows expression of His-Nat2 at 34 kDa. Lanes: 1, whole cells; 2, soluble fraction; 3, unbound wash; 4, 0 mM imidazole (IMZ) wash; 5, 1 mM IMZ wash; 6, 10 mM IMZ wash; 7, 20 mM IMZ wash; 8, 50 mM IMZ wash; 9, first 100 mM IMZ wash; 10, second 100 mM IMZ wash; M, low-range molecular weight markers (BioRad). Thrombin cleavage of His-Nat2. Purified His-Nat2 was incubated with thrombin (5 U/mg NAT) at 4 degreesC for 6 h for complete His-tag cleavage. Lanes: M, low-range molecular weight marker (BioRad); 1, His-Nat2 only (8 mug); 2, thrombin-treated, Nat2 (8 mug).
###end p 106
###begin p 107
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">2</xref>
###xml 814 817 803 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">[2]</xref>
###xml 860 861 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">2</xref>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 253 258 <span type="species:ncbi:10090">mouse</span>
###xml 356 361 <span type="species:ncbi:10090">mouse</span>
###xml 774 779 <span type="species:ncbi:9606">human</span>
Comparison of the substrate specific activity profiles of mouse Nat2, human NAT1 and human NAT2. The substrate specific activity profiles for mouse Nat2 (grey bars), human NAT1 (cross-hatched bars) and human NAT2 (black bars) are shown. The activity of mouse Nat2 was determined by measuring the rate of CoA production, as described in Section 2. Purified mouse Nat2 (0.125 mug) was incubated with arylamine substrate (each at 500 muM) and AcCoA (400 muM) in assay buffer (20 mM Tris-HCl (pH 8.0)) containing 0.5% (v/v) DMSO at 25 degreesC. The specific activities were determined from the linear initial rates of reaction. All measurements were performed in triplicate and are expressed as mean +/- standard deviation relative to the most rapidly acetylated substrate. The human NAT1 and NAT2 data are taken from [2]. The abbreviations are defined in Section 2.
###end p 107
###begin p 108
###xml 49 61 49 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. smegmatis</italic>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</italic>
###xml 531 535 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib47" ref-type="bibr">[47]</xref>
###xml 49 61 <span type="species:ncbi:1772">M. smegmatis</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 329 334 <span type="species:ncbi:9606">human</span>
###xml 474 479 <span type="species:ncbi:9606">human</span>
Comparison of the crystal structures of NAT from M. smegmatis (MSNAT) and human NAT1. The surface shown was calculated from the MSNAT crystal structure (PDB accession code 1GX3), and the human NAT1 crystal structure F125S mutant (PDB accession code 2IJA) is shown in ribbon format. The C-terminus and inter-domain loop region of human NAT1 protrude from the eukaryotic protein core, and both of these protein regions block the prokaryotic NAT active site. The C-terminus of human NAT1 is found in the region termed the 'beta-site' [47].
###end p 108
###begin p 109
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr">[33]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib48" ref-type="bibr">[48]</xref>
###xml 558 560 558 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">68</sup>
###xml 565 568 565 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">107</sup>
###xml 576 579 576 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">122</sup>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib49" ref-type="bibr">[49]</xref>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
###xml 250 255 <span type="species:ncbi:9606">human</span>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
###xml 325 330 <span type="species:ncbi:10090">mouse</span>
###xml 654 659 <span type="species:ncbi:10090">mouse</span>
###xml 805 810 <span type="species:ncbi:9606">human</span>
###xml 858 863 <span type="species:ncbi:10090">mouse</span>
###xml 889 894 <span type="species:ncbi:9606">human</span>
###xml 943 948 <span type="species:ncbi:10090">mouse</span>
(a) and (b) The structure of mouse Nat2. The mouse Nat2 protein structure was produced by homology modelling with the program Modeller 8v2 [33]. The human NAT1 crystal structure (PDB code 2IJA) was used as a template, and the amino acid sequences of human NAT1 and mouse Nat2 were aligned with the program ClustalW [48]. The mouse Nat2 ribbon structure is shown in green. The ribbon structures of the inter-domain loop region and C-terminal hexapeptide residues (residues 168-184 and 285-290) are shown in dark green, and the active site catalytic triad (Cys68, His107 and Asp122) residues are shown in ball and stick representation. The pdb file of the mouse Nat2 homology model is available upon request. The figure was produced with Aesop, as previously described [49]. (c) and (d) A comparison of the human NAT1 crystal structure (PDB code 2IJA) and the mouse Nat2 homology model. The human NAT1 crystal structure is shown in blue and the mouse Nat2 model is shown in green. The two proteins share 82% identity at the amino acid level. Over 1191 equivalent atoms, the two structures have a root mean squared deviation of 0.75 A. The catalytic triad residues for both proteins are shown in ball and stick representation. The views in (b) and (d) were obtained by rotating the structures shown in (a) and (c) by 30degrees. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of the article.)
###end p 109
###begin p 110
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 14 16 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
750 MHz 2D 1H-15N HSQC spectrum of mouse Nat2.
###end p 110
###begin p 111
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 209 211 209 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">67</sup>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">132</sup>
###xml 257 258 257 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</sup>
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
The downfield region of the 1D 1H NMR spectra of (A) mouse and (B) hamster Nat2 collected using a jump-return pulse sequence. These peaks arise from the indole HN of two tryptophan residues (peaks 2 and 3, Trp67 and Trp132 respectively) and from imidazole HN of histidine (peaks 1 and 4, His).
###end p 111
###begin p 112
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">132</sup>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
The mouse Nat2 homology model, based on the crystal structure of human NAT1, showing the position of Trp132 relative to the active-site triad (shown in ball and stick representation). The putative phosphate-binding P-loop is shown.
###end p 112
###begin p 113
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
The downfield region of the 1D 1H NMR spectra obtained in a titration of mouse Nat2 with bisphenol A. Spectra collected with 0-8 equivalents of bisphenol A are shown. Peaks are observed to shift and to broaden as increasing amounts of bisphenol A are added; this broadening may indicate chemical exchange within the bound protein. Some precipitation of protein was observed with 8 equivalents of bisphenol A, which is likely to account for the decrease in peak intensity in this spectrum.
###end p 113
###begin p 114
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Titration of mouse Nat2 with bisphenol A. The magnitudes of changes in chemical shift observed for the four downfield shifted peaks are shown as a function of the amount of added bisphenol A. The largest shifts are observed for peaks 1 (filled circle) and 4 (open square) which arise from histidine; smaller shifts are observed for peaks 2 (open triangle) and 3 (filled triangle).
###end p 114
###begin p 115
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Purification of mouse Nat2
###end p 115
###begin p 116
###xml 136 137 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="sec1" ref-type="sec">2</xref>
###xml 249 254 242 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mNAT2</sub>
###xml 264 266 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 269 271 262 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
NAT activities were measured by determining the rate of acetylation of the arylamine substrate, PABA (100 muM), as described in Section 2. Protein concentrations were measured by using the Bradford assay (*) and absorbance (**) at 280 nm (epsilon280mNAT2 = 40920 M-1 cm-1).
###end p 116
###begin p 117
NAT inhibition by steroidogenic compounds
###end p 117
###begin p 118
###xml 76 96 76 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 1</xref>
###xml 136 138 136 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 269 289 268 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 1</xref>
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
The steroidogenic compounds which have shown inhibition against mouse Nat2 (Supplementary Fig. 1) were further investigated and their IC50 values were determined by varying the inhibitor concentrations (1-500 muM) under the same experimental conditions as described in Supplementary Fig. 1.
###end p 118
###begin p 119
###xml 39 41 39 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Nat2 inhibitory concentration (IC50) of xenobiotic oestrogens
###end p 119
###begin p 120
###xml 122 142 122 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 1</xref>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
Half-maximal inhibitory concentrations of xenobiotic oestrogens against mouse Nat2 were measured as previously described (Supplementary Fig. 1).
###end p 120
###begin p 121
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
Summary of peaks observed in the downfield region (10.5-13 ppm) of the spectra of hamster and mouse Nat2
###end p 121

